Multicenter phase II trial of neoadjuvant chemotherapy with docetaxel and nedaplatin for oral squamous cell carcinoma.

Trial Profile

Multicenter phase II trial of neoadjuvant chemotherapy with docetaxel and nedaplatin for oral squamous cell carcinoma.

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Jan 2012

At a glance

  • Drugs Docetaxel (Primary) ; Nedaplatin (Primary)
  • Indications Oropharyngeal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Jan 2010 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 04 Jun 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top